Skip to main navigation Skip to search Skip to main content

Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients

Translated title of the contribution: Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients
  • J.A. Erkens
  • , O.H. Klungel
  • , R.M.C. Herings
  • , R.P. Stolk
  • , J.A. Spoelstra
  • , D.E. Grobbee
  • , H.G.M. Leufkens

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionUse of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients
Original languageUndefined/Unknown
Pages (from-to)1575-1579
Number of pages5
JournalEuropean Heart Journal
Volume23
Publication statusPublished - 2002

Keywords

  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this